About the Research Group
Mission
- Develops, implements and monitors research efforts for prostate and urogenital cancers in the areas of chemoprevention, nutrition, and other prevention strategies that include nutritional, pharmacologic, biologic, genetic, vaccines, or immunologic interventions and cancer screening and early detection.
- Develops and implements research through clinical trials, screening, testing and validating new technologies that identify premalignant lesions.
- Monitors clinical trials to develop agents using measures of efficacy that include modulation of surrogate endpoint biomarkers or cancer incidence reduction.
- Interacts and communicates with extramural and intramural investigators in other NCI divisions and organizations of the National Cancer Program.
Staff
- Margaret House, RN, OCN
- Howard Parnes, MD
- Joe Tangrea, MPH, PhD
Phone
(240) 276-7140
US Mail Address
Prostate and Urologic Cancer Research Group
Division of Cancer Prevention
National Cancer Institute
9609 Medical Center Drive
MSC 9783
Bethesda, MD 20892-9783
Commercial Delivery Address
Prostate and Urologic Cancer Research Group
Division of Cancer Prevention
National Cancer Institute
9609 Medical Center Drive
Rockville, MD 20850
Back to top
